The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine
- 10 April 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 196 (1) , 103-108
- https://doi.org/10.1016/0014-2999(91)90414-l
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The nucleus accumbens and forelimb muscular rigidity in ratsExperimental Brain Research, 1988
- Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonistsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphismLife Sciences, 1988
- The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugsPsychopharmacology, 1987
- Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of actionEuropean Journal of Pharmacology, 1987
- Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivoEuropean Journal of Pharmacology, 1986
- Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: Tonic EMG activity in ratsBrain Research, 1985
- Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neuronsJournal of Neuroscience, 1985
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963